Trial Profile
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 16 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Aug 2010 New trial record